Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [522]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Comment: Immunotherapy combo increases median survival in advanced melanoma
Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA
Comment: Immunotherapy combo increases median survival in advanced melanoma ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )
2 Jun 2014
Success for ipilimumab and nivolumab combo in advanced melanoma
Prof Mario Sznol - Yale Cancer Center, New Haven, USA
Success for ipilimumab and nivolumab combo in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )
2 Jun 2014
ASCO 2014 roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014
T-VEC injections into melanoma lesions show significant response rate
Prof Kevin Harrington - Institute of Cancer Research, London, UK
T-VEC injections into melanoma lesions show significant response rate ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )
2 Jun 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
1 May 2014
Immunotherapy in melanoma
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
Promising advances in the treatment of lung cancer using MK-3475 as an immune...
Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston...
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
16 Apr 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation